Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2013
11/05/2013US8574582 Methods for mediating fibrotic response
11/05/2013US8574581 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
11/05/2013US8574580 Monoclonal antibodies that recognize neurospheres or neural progenitor cells
11/05/2013US8574579 Anti-IL-23 antibodies
11/05/2013US8574578 Antibodies against PDGFRα to inhibit tumor growth
11/05/2013US8574577 VEGF antibodies comprising modular recognition domains
11/05/2013US8574576 Humanized anti-EGFL7 antibodies and methods using same
11/05/2013US8574575 RS7 antibodies
11/05/2013US8574574 Pharmaceutical composition comprising antibody composition which specifically binds to CCR4
11/05/2013US8574573 Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
11/05/2013US8574572 Method of treating pulmonary disease by administering an antibody to G-CSF receptor
11/05/2013US8574571 Methods and compositions for modulating wound repair
11/05/2013US8574315 Electrospun structures and methods for forming and using same
11/05/2013CA2745096C Immunostimulatory oligonucleotides
11/05/2013CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
11/05/2013CA2514485C Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
11/05/2013CA2398979C Novel bee venom polypeptides and methods of use thereof
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2328403C Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
10/2013
10/31/2013WO2013163630A1 Modified antibody regions and uses thereof
10/31/2013WO2013163519A1 Anti-cd22 antibodies
10/31/2013WO2013163512A1 Agents and methods for treating and preventing seborrheic keratosis
10/31/2013WO2013163479A1 Methods and compositions for treating and diagnosing acute myocardial infarction
10/31/2013WO2013163427A1 Antibodies to treat hiv-1 infection
10/31/2013WO2013163337A1 Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
10/31/2013WO2013163297A1 Modified glycoproteins
10/31/2013WO2013163229A1 Dr5 ligand drug conjugates
10/31/2013WO2013163176A1 Nanoparticles for treatment of allergy
10/31/2013WO2013162751A1 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
10/31/2013WO2013162748A1 Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
10/31/2013WO2013161895A1 Bone repair promoter
10/31/2013WO2013161814A1 Anti-human cd69 antibody, and use thereof for medical purposes
10/31/2013WO2013160913A1 Rotavirus vaccine compositions and process for preparing the same
10/31/2013WO2013160894A1 Methods and compositions for treating cancer
10/31/2013WO2013160879A1 Anti-robo4-antibody
10/31/2013WO2013160865A1 Immunotolerizing fusion proteins for treatment of multiple sclerosis
10/31/2013WO2013160498A1 Human anti-her2 monoclonal antibody
10/31/2013WO2013160396A1 Combination of cd37 antibodies with bendamustine
10/31/2013WO2013160359A1 Anti-pdgf-c antibodies
10/31/2013WO2013160335A2 Antigens and antigen combinations
10/31/2013WO2013159234A1 Glycoengineered outer membrane vesicles and use thereof as vaccines
10/31/2013WO2013159155A1 Oncolytic clostridium ghonii strains, and methods of production and use
10/31/2013WO2013130672A3 Improved cancer treatments and diagnostics
10/31/2013WO2013119960A3 Anti-cd324 monoclonal antibodies and uses thereof
10/31/2013WO2013114240A3 Method for obtaining glycoprotein composition
10/31/2013WO2013111014A3 Methods and compositions for treating neuron loss in inflammatory bowel disease
10/31/2013WO2013101993A3 Dual variable domain immunoglobulins against receptors
10/31/2013WO2012058460A3 Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
10/31/2013WO2012054077A3 Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
10/31/2013WO2002101078A9 Cellulases, nucleic acids encoding them and methods for making and using them
10/31/2013WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013US20130288362 Compositions and methods for producing adaptive regulatory t cells
10/31/2013US20130288338 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
10/31/2013US20130287857 Vaccine Nanotechnology
10/31/2013US20130287838 Vaccine engineering
10/31/2013US20130287812 anti-HPV drug and its application in preparing medicines for treatment of HPV (human papilloma virus) infection
10/31/2013US20130287811 Method for Producing Viral Vaccines
10/31/2013US20130287810 Vaccine compositions and uses thereof
10/31/2013US20130287809 Mycobacterium antigenic composition
10/31/2013US20130287808 Vaccines for preventing meningococcal infections
10/31/2013US20130287807 Compounds for treating symptoms associated with parkinson's disease
10/31/2013US20130287806 Immune-modulating agents and uses therefor
10/31/2013US20130287805 C18orf54 peptides and vaccines including the same
10/31/2013US20130287800 Immunization with amyloid-beta oligomers
10/31/2013US20130287797 Combination of cd37 antibodies with bendamustine
10/31/2013US20130287794 Methods for the treatment or prevention of systemic sclerosis
10/31/2013US20130287792 Compositions and methods to block mtb-mediated evasion
10/31/2013US20130287791 Modulation of histone h2b monoubiquitination and treatment of cancer
10/31/2013US20130287788 Treatment of Psychiatric Conditions
10/31/2013US20130287787 Monoclonal antibodies that react with the capsule of bacillus anthracis
10/31/2013US20130287786 Canine babesiosis vaccine antigen
10/31/2013US20130287785 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
10/31/2013US20130287784 Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy
10/31/2013US20130287782 Enterococcus antigens
10/31/2013US20130287779 Humanized anti-egfl7 antibodies and methods using same
10/31/2013US20130287778 Means and methods for treating dlbcl
10/31/2013US20130287776 Anti-fgfr3 antibodies and methods using same
10/31/2013US20130287775 Combination therapy for treatment of immune disorders
10/31/2013US20130287774 Prevention of Adverse Effects Caused by CD3 Specific Binding Domains
10/31/2013US20130287769 Treatment of solid tumors with rapamycin derivatives
10/31/2013US20130287768 Pharmaceutical composition comprising antibody composition which specifically binds to ccr4
10/31/2013US20130287765 Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis
10/31/2013US20130287764 Method for inhibiting bone resorption
10/31/2013US20130287763 Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitor
10/31/2013US20130287693 NOGO Receptor Binding Protein
10/31/2013US20130287684 Anti-her3 antibodies and compositions
10/30/2013EP2657333A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
10/30/2013EP2657253A2 Anti-CD79b antibodies and immunoconjugates and methods of use
10/30/2013EP2657251A1 Live, oral vaccine for protection against Shigella dysenteriae serotype 1
10/30/2013EP2657235A1 Compound containing basic group and use thereof
10/30/2013EP2656859A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins
10/30/2013EP2656833A1 Crosslinked Hyaluronic Acid Compositions For Tissue Augmentation
10/30/2013EP2656073A2 Modulating agonistic tnfr antibodies
10/30/2013EP2656070A1 Determination of the efficacy of an anti-mycobacterial vaccination
10/30/2013EP2655668A1 Novel bacterium and extracts of said bacterium and the use of same in therapy
10/30/2013EP2655613A1 Virus like particle production in plants
10/30/2013EP2655604A1 Adenovirus serotype 26 and serotype 35 filovirus vaccines
10/30/2013EP2655419A1 Anti-pcsk9 antibodies and methods of use
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 1823